Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $17.9 million.

  • Cross Country Healthcare's Net Cash Flow rose 42109.32% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.1 million, marking a year-over-year decrease of 2937.64%. This contributed to the annual value of $64.6 million for FY2024, which is 37880.88% up from last year.
  • Cross Country Healthcare's Net Cash Flow amounted to $17.9 million in Q3 2025, which was up 42109.32% from $494000.0 recorded in Q2 2025.
  • Over the past 5 years, Cross Country Healthcare's Net Cash Flow peaked at $64.4 million during Q2 2024, and registered a low of -$26.7 million during Q4 2022.
  • Its 5-year average for Net Cash Flow is $5.1 million, with a median of $381000.0 in 2023.
  • As far as peak fluctuations go, Cross Country Healthcare's Net Cash Flow plummeted by 1545402.3% in 2022, and later soared by 1679212.6% in 2024.
  • Cross Country Healthcare's Net Cash Flow (Quarter) stood at $174000.0 in 2021, then tumbled by 15454.02% to -$26.7 million in 2022, then skyrocketed by 110.42% to $2.8 million in 2023, then surged by 533.35% to $17.6 million in 2024, then increased by 1.65% to $17.9 million in 2025.
  • Its Net Cash Flow stands at $17.9 million for Q3 2025, versus $494000.0 for Q2 2025 and -$930000.0 for Q1 2025.